MDPI Subject Workshop “Precision Medicine and Personalised Healthcare"

Schedule

Fri Jan 08 2027 at 09:30 am to 05:30 pm

UTC+00:00
Location

King's College London | London, EN

Advertisement
MDPI UK is delighted to announce its upcoming Subject Workshop, “Precision Medicine and Personalised Healthcare”.
About this Event

MDPI UK's Precision Medicine and Personalised Healthcare Subject Workshop event will be held on Friday 8th January 2027 at King’s College London and will feature talks from guest speakers working across precision medicine and personalised healthcare.

Precision therapies are treatments tailored to a patient’s unique genetic and biomarker profile to deliver more targeted and effective care. Breakthroughs in multi-omics profiling, engineering biology and advanced drug delivery systems are rapidly transforming how these personalised treatments are designed and targeted to disease sites, while minimising side effects. Paired with advanced imaging modalities, emerging diagnostics and artificial intelligence, these innovations are unlocking new possibilities for treating complex conditions—from aggressive cancers to difficult-to-treat paediatric and rare genetic diseases. This workshop will cover the key technologies driving precision therapies forward, alongside studies translating these breakthroughs into clinical practice.

This event seeks to bring together those working in the field to showcase their work, network with other industry and academic professionals, and learn about the advances shaping the landscape of precision medicine and personalised healthcare.



Event Details

Date: Friday 8th January 2027

Time: 09:30–17:30

Venue: The Great Hall, King's College London, Strand Campus, Strand, London, WC2R 2LS

Cost: A £5 registration fee applies for this event. All proceeds from ticket sales will be donated to a charity funding medical research, which will be chosen in collaboration with the event’s Chair. Refreshments and lunch will be provided courtesy of MDPI.


About our Chair

Prof. Dr. Moein Moghimi is Professor of Pharmaceutics and Nanomedicine at Newcastle University, Adjoint Professor at the University of Colorado Denver, and Co-Founder of S. M. Discovery Group. Ranked among the world’s top 50 scientists in pharmacology and Ph*rm*cy, he is an internationally recognised pioneer in nanomedicine, site-specific drug delivery, nanosafety and engineering biology. His foundational discoveries on how engineered advanced therapeutics interact with the immune system and overcome biological barriers have established core principles for designing safer, targeted precision treatments. Alongside his research, he serves as Editor-in-Chief of the Journal of Nanotheranostics (MDPI) and Drug Delivery (Taylor & Francis), and Associate Editor of Molecular Therapy, the flagship journal of the American Society of Gene and Cell Therapy (Cell Press).



Why attend?
  • Learn about groundbreaking developments in the field of personalised healthcare and precision medicine.
  • Hear from experts in the field about the direct impact of these developments on patient groups.
  • Engage in a roundtable discussion with experts in the field about research breakthroughs and key questions regarding future innovation.
  • Network with academics and industry leaders working in your field.
  • Connect with the MDPI UK team in person.



Who is this event open to?

Academics, industry professionals, early-career researchers, and PhD students working in the field or with an interest in the topics of precision medicine and personalised healthcare are invited to attend this event.


If you have any questions, please feel free to contact us at [email protected]

Advertisement

Where is it happening?

King's College London, Strand, London, United Kingdom

Event Location & Nearby Stays:

Tickets

GBP 5.00

Know what’s Happening Next — before everyone else does.
MDPI
Host or PublisherMDPI

Ask AI if this event suits you